Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021301
Company: KING PHARMS
Company: KING PHARMS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| LEVOXYL | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription | AB1,AB3 | Yes | No |
| LEVOXYL | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription | AB1,AB3 | Yes | No |
| LEVOXYL | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription | AB1,AB3 | Yes | No |
| LEVOXYL | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription | AB1,AB3 | Yes | No |
| LEVOXYL | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription | AB1,AB3 | Yes | No |
| LEVOXYL | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription | AB1,AB3 | Yes | No |
| LEVOXYL | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription | AB1,AB3 | Yes | No |
| LEVOXYL | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription | AB1,AB3 | Yes | No |
| LEVOXYL | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription | AB1,AB3 | Yes | No |
| LEVOXYL | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription | AB1,AB3 | Yes | No |
| LEVOXYL | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription | AB1,AB3 | Yes | Yes |
| LEVOXYL | LEVOTHYROXINE SODIUM | 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL | Discontinued | None | Yes | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 12/20/2018 | SUPPL-38 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021301s038lbl.pdf | |
| 03/21/2011 | SUPPL-27 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021301s027lbl.pdf | |
| 03/21/2011 | SUPPL-27 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021301s027lbl.pdf | |
| 07/08/2008 | SUPPL-26 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021301s026lbl.pdf | |
| 03/08/2005 | SUPPL-14 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/21301s014lbl.pdf | |
| 05/25/2001 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21301lbl.pdf |